Investigating how platelet-derived growth factor receptors direct synovialfibroblast-mediated pathology in inflammatory arthritis
研究血小板衍生生长因子受体如何指导炎症关节炎中滑膜成纤维细胞介导的病理学
基本信息
- 批准号:10247966
- 负责人:
- 金额:$ 38.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-10 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AntibodiesArthritisAtherosclerosisAutoimmune ProcessAutomobile DrivingBioinformaticsBiologyCartilageCell physiologyCellsClinicalClinical TrialsCustomDataDevelopmentDiseaseDisease remissionDrug CombinationsEye diseasesFc ReceptorFibroblastsFibrosisFlow CytometryFutureGene ExpressionGeneticGenetic TranscriptionGoalsHealthHeterodimerizationHomoHumanHyperplasiaImmunosuppressionIn VitroInflammationInflammatoryInflammatory ArthritisJointsKnowledgeLigandsMalignant NeoplasmsMediatingMembraneMethodsMissionModelingMonoclonal AntibodiesMorphologyMusPathogenesisPathologicPathologyPathway interactionsPatientsPatternPharmaceutical PreparationsPhenotypePlatelet-Derived Growth FactorPlatelet-Derived Growth Factor ReceptorPlatelet-Derived Growth Factor alpha ReceptorPopulationPublic HealthReceptor ActivationReceptor SignalingResearchRheumatoid ArthritisRiskSerumShapesSignal TransductionStimulusStromelysin 1SurfaceSynovial CellSynovial MembraneTNF geneTestingTherapeuticTissuesUnited States National Institutes of Healthaptamerautoimmune arthritisbasebone erosioncadherin-11cell typefunctional outcomesimprovedin vitro Assayinfection riskinnovationjoint inflammationmigrationmouse modelnano-stringnovelnovel therapeutic interventionnovel therapeuticsplatelet-derived growth factor BBpre-clinicalpreventreceptorreceptor expressiontherapeutic developmenttooltranscriptome sequencingtreatment response
项目摘要
PROJECT SUMMARY/ABSTRACT
There is a fundamental gap in understanding of how different types of synovial fibroblasts contribute to
rheumatoid arthritis (RA) pathology, restricting the ability to block fibroblast-mediated joint inflammation and
cartilage erosions. The long-term goal driving this proposal is to identify ways to specifically target fibroblast
function in inflammatory arthritis. The objective of this proposal to investigate platelet-derived growth factor
receptors (PDGFRs) as one of these targets. Although PDGFRs are potent stimulators of fibroblast
proliferation and migration and are known to be upregulated in RA, PDGFR research in inflammatory arthritis
has lagged behind other disease fields. The rationale for this study is that it will advance new therapeutic
approaches in autoimmune inflammatory arthritis by both developing preclinical data to support an arthritis
indication for newly developed anti-PDGFR therapeutics and by discovering novel fibroblast pathways for
future clinical targeting. The central hypothesis shaping this proposal is that that PDGFRα and PDGFRβ
independently contribute to the development of inflammatory arthritis and fibroblast-mediated joint pathology.
This hypothesis is built on preliminary data showing different functional outcomes following PDGFRα or
PDGFRβ activation in RA synovial fibroblasts and demonstrating that different fibroblast subpopulations can be
isolated directly from the synovium based on PDGFRα and PDGFRβ expression. This hypothesis will be tested
in three specific aims: (1) Determine how PDGFRα and PDGFRβ expression regulates inflammatory arthritis
development; (2) Determine how PDGFRα and PDGFRβ activation is regulated in synovial fibroblasts; and (3)
Test anti-PDGFR treatment combinations in a preclinical inflammatory arthritis model. Aim 1 uses inducible
genetic deletion of PDGFRs to test their function in arthritis development in a mouse model and correlates this
function with the transcriptional profiles of PDGFR-expressing fibroblast populations isolated directly from the
synovium. Aim 2 isolates differential effects of PDGFRα and PDGFRβ activation in synovial fibroblasts by
examining gene expression, membrane interactions, and ligand availability. Aim 3 uses the preclinical serum
transfer mouse arthritis model to test how anti-PDGFR antibodies may augment arthritis treatment when
combined with other types of therapies. This approach is innovative, in the applicant's opinion, because it
reenergizes PDGFR research in RA by combining genetic tools developed for other diseases with new flow
cytometric and bioinformatic methods to analyze fibroblast function both in vitro and directly ex vivo. The
proposed research is significant because determining how PDGFRα and PDGFRβ expression and signaling
regulates fibroblast and synovial biology is expected to assess how new PDGF-specific drugs can be used to
treat RA and to increase our fundamental understanding of how different synovial fibroblast populations
contribute to inflammatory arthritis pathogenesis.
项目总结/摘要
在理解不同类型的滑膜成纤维细胞如何促进
类风湿性关节炎(RA)病理,限制阻断成纤维细胞介导的关节炎症的能力,
软骨糜烂推动这项提案的长期目标是确定专门针对成纤维细胞的方法
在炎症性关节炎中的作用。本提案的目的是研究血小板衍生生长因子
PDGFRs作为这些靶点之一。尽管PDGFRs是成纤维细胞的有效刺激物,
在炎症性关节炎的PDGFR研究中,
已经落后于其他疾病领域。这项研究的基本原理是,它将推动新的治疗方法,
自身免疫性炎症性关节炎的方法,通过开发临床前数据来支持关节炎
新开发的抗PDGFR疗法的适应症,并通过发现新的成纤维细胞途径,
未来的临床目标形成这一提议的中心假设是PDGFRα和PDGFRβ
独立地促进炎性关节炎和成纤维细胞介导的关节病理学的发展。
该假设建立在初步数据基础上,初步数据显示PDGFRα或
RA滑膜成纤维细胞中的PDGFRβ激活,并证明不同的成纤维细胞亚群可以被激活。
基于PDGFRα和PDGFRβ表达直接从滑膜分离。这一假设将得到检验
有三个具体目标:(1)确定PDGFRα和PDGFRβ表达如何调节炎症性关节炎
(2)确定滑膜成纤维细胞中PDGFRα和PDGFRβ的活化是如何调节的;以及(3)
在临床前炎性关节炎模型中测试抗PDGFR治疗组合。Aim 1使用诱导型
PDGFRs的遗传缺失以测试其在小鼠模型中关节炎发展中的功能并与其相关
PDGFR表达的成纤维细胞群的转录谱的功能,这些成纤维细胞群直接从
滑膜目的2:分离滑膜成纤维细胞中PDGFRα和PDGFRβ激活的差异效应,
检测基因表达、膜相互作用和配体可用性。目的3使用临床前血清
转移小鼠关节炎模型,以测试抗PDGFR抗体如何增强关节炎治疗,
与其他类型的疗法相结合。申请人认为,这种方法是创新的,因为它
通过将为其他疾病开发的遗传工具与新的流动相结合,
细胞计数和生物信息学方法来分析体外和直接离体的成纤维细胞功能。的
提出的研究是重要的,因为确定PDGFRα和PDGFRβ的表达和信号传导
调节成纤维细胞和滑膜生物学,预计将评估新的PDGF特异性药物如何用于
治疗RA,并增加我们对不同滑膜成纤维细胞群
有助于炎症性关节炎的发病机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jan Christian Lood其他文献
Jan Christian Lood的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jan Christian Lood', 18)}}的其他基金
Role of mitochondria in SLE and its cardiovascular complications
线粒体在 SLE 及其心血管并发症中的作用
- 批准号:
10473713 - 财政年份:2021
- 资助金额:
$ 38.83万 - 项目类别:
Extracellular mitochondria in Inclusion Body Myositis
包涵体肌炎的细胞外线粒体
- 批准号:
10282390 - 财政年份:2021
- 资助金额:
$ 38.83万 - 项目类别:
Role of mitochondria in SLE and its cardiovascular complications
线粒体在 SLE 及其心血管并发症中的作用
- 批准号:
10274520 - 财政年份:2021
- 资助金额:
$ 38.83万 - 项目类别:
Role of mitochondria in SLE and its cardiovascular complications
线粒体在 SLE 及其心血管并发症中的作用
- 批准号:
10652483 - 财政年份:2021
- 资助金额:
$ 38.83万 - 项目类别:
Mitochondrial calcification in juvenile dermatomyositis
幼年皮肌炎的线粒体钙化
- 批准号:
10245228 - 财政年份:2020
- 资助金额:
$ 38.83万 - 项目类别:
Investigating how platelet-derived growth factor receptors direct synovialfibroblast-mediated pathology in inflammatory arthritis
研究血小板衍生生长因子受体如何指导炎症关节炎中滑膜成纤维细胞介导的病理学
- 批准号:
10260607 - 财政年份:2020
- 资助金额:
$ 38.83万 - 项目类别:
Mitochondrial calcification in juvenile dermatomyositis
幼年皮肌炎的线粒体钙化
- 批准号:
10027222 - 财政年份:2020
- 资助金额:
$ 38.83万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Elucidation of mechanism and disease-specific biomarkers of atherosclerosis in rheumatoid arthritis
阐明类风湿性关节炎动脉粥样硬化的机制和疾病特异性生物标志物
- 批准号:
16K08949 - 财政年份:2016
- 资助金额:
$ 38.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Abnormal adaptive immunity, endothelial dysfunction and accelerated atherosclerosis in Rheumatoid Arthritis
类风湿性关节炎的适应性免疫异常、内皮功能障碍和加速动脉粥样硬化
- 批准号:
285965097 - 财政年份:2015
- 资助金额:
$ 38.83万 - 项目类别:
Research Fellowships
Mechanisms Linking Joint Inflammation and Atherosclerosis in Rheumatoid Arthritis
类风湿关节炎中关节炎症和动脉粥样硬化的联系机制
- 批准号:
8818588 - 财政年份:2014
- 资助金额:
$ 38.83万 - 项目类别:
Mechanisms Linking Joint Inflammation and Atherosclerosis in Rheumatoid Arthritis
类风湿关节炎中关节炎症和动脉粥样硬化的联系机制
- 批准号:
8965517 - 财政年份:2014
- 资助金额:
$ 38.83万 - 项目类别:
Treat to Target to Reduce Atherosclerosis in Rheumatoid Arthritis
治疗以减少类风湿性关节炎的动脉粥样硬化为目标
- 批准号:
8641657 - 财政年份:2013
- 资助金额:
$ 38.83万 - 项目类别:
Treat to Target to Reduce Atherosclerosis in Rheumatoid Arthritis
治疗以减少类风湿性关节炎的动脉粥样硬化为目标
- 批准号:
8435756 - 财政年份:2013
- 资助金额:
$ 38.83万 - 项目类别:
Inflammation and Atherosclerosis in Rheumatoid Arthritis
类风湿性关节炎的炎症和动脉粥样硬化
- 批准号:
7750674 - 财政年份:2009
- 资助金额:
$ 38.83万 - 项目类别:
Inflammation and Atherosclerosis in Rheumatoid Arthritis
类风湿性关节炎的炎症和动脉粥样硬化
- 批准号:
7919318 - 财政年份:2009
- 资助金额:
$ 38.83万 - 项目类别:
Inflammation-associated S100 proteins: links between arthritis and atherosclerosis
炎症相关 S100 蛋白:关节炎和动脉粥样硬化之间的联系
- 批准号:
nhmrc : 455306 - 财政年份:2007
- 资助金额:
$ 38.83万 - 项目类别:
NHMRC Project Grants
Inflammation and atherosclerosis in rheumatoid arthritis
类风湿性关节炎的炎症和动脉粥样硬化
- 批准号:
18591121 - 财政年份:2006
- 资助金额:
$ 38.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)